Search: WFRF:(Kaaks Rudolf) > Dietary Advanced Gl...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 04931naa a2200865 4500 | |
001 | oai:DiVA.org:umu-190623 | |
003 | SwePub | |
008 | 211220s2021 | |||||||||||000 ||eng| | |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-1906232 URI |
024 | 7 | a https://doi.org/10.3390/nu130931322 DOI |
040 | a (SwePub)umu | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Aglago, Elom K.4 aut |
245 | 1 0 | a Dietary Advanced Glycation End-Products and Colorectal Cancer Risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) Study |
264 | c 2021-09-08 | |
264 | 1 | b MDPI,c 2021 |
338 | a electronic2 rdacarrier | |
520 | a Dietary advanced glycation end-products (dAGEs) have been hypothesized to be associated with a higher risk of colorectal cancer (CRC) by promoting inflammation, metabolic dysfunction, and oxidative stress in the colonic epithelium. However, evidence from prospective cohort studies is scarce and inconclusive. We evaluated CRC risk associated with the intake of dAGEs in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Dietary intakes of three major dAGEs: Nε-carboxy-methyllysine (CML), Nε-carboxyethyllysine (CEL), and Nδ-(5-hydro-5-methyl-4-imidazolon-2-yl)-ornithine (MG-H1) were estimated in 450,111 participants (median follow-up = 13 years, with 6162 CRC cases) by matching to a detailed published European food composition database. Hazard ratios (HRs) and 95% confidence intervals (CIs) for the associations of dAGEs with CRC were computed using multivariable-adjusted Cox regression models. Inverse CRC risk associations were observed for CML (HR comparing extreme quintiles: HRQ5vs.Q1 = 0.92, 95% CI = 0.85-1.00) and MG-H1 (HRQ5vs.Q1 = 0.92, 95% CI = 0.85-1.00), but not for CEL (HRQ5vs.Q1 = 0.97, 95% CI = 0.89-1.05). The associations did not differ by sex or anatomical location of the tumor. Contrary to the initial hypothesis, our findings suggest an inverse association between dAGEs and CRC risk. More research is required to verify these findings and better differentiate the role of dAGEs from that of endogenously produced AGEs and their precursor compounds in CRC development. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Hälsovetenskapx Näringslära0 (SwePub)303042 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Health Sciencesx Nutrition and Dietetics0 (SwePub)303042 hsv//eng |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Cancer och onkologi0 (SwePub)302032 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Cancer and Oncology0 (SwePub)302032 hsv//eng |
653 | a advanced glycation end-products | |
653 | a colorectal cancer | |
653 | a dietary exposure | |
653 | a dietary glycation compounds | |
700 | 1 | a Mayén, Ana-Lucia4 aut |
700 | 1 | a Knaze, Viktoria4 aut |
700 | 1 | a Freisling, Heinz4 aut |
700 | 1 | a Fedirko, Veronika4 aut |
700 | 1 | a Hughes, David J.4 aut |
700 | 1 | a Jiao, Li4 aut |
700 | 1 | a Eriksen, Anne Kirstine4 aut |
700 | 1 | a Tjønneland, Anne4 aut |
700 | 1 | a Boutron-Ruault, Marie-Christine4 aut |
700 | 1 | a Rothwell, Joseph A.4 aut |
700 | 1 | a Severi, Gianluca4 aut |
700 | 1 | a Kaaks, Rudolf4 aut |
700 | 1 | a Katzke, Verena4 aut |
700 | 1 | a Schulze, Matthias B.4 aut |
700 | 1 | a Birukov, Anna4 aut |
700 | 1 | a Palli, Domenico4 aut |
700 | 1 | a Sieri, Sabina4 aut |
700 | 1 | a Santucci de Magistris, Maria4 aut |
700 | 1 | a Tumino, Rosario4 aut |
700 | 1 | a Ricceri, Fulvio4 aut |
700 | 1 | a Bueno-de-Mesquita, Bas4 aut |
700 | 1 | a Derksen, Jeroen W. G.4 aut |
700 | 1 | a Skeie, Guri4 aut |
700 | 1 | a Gram, Inger Torhild4 aut |
700 | 1 | a Sandanger, Torkjel4 aut |
700 | 1 | a Quirós, J. Ramón4 aut |
700 | 1 | a Luján-Barroso, Leila4 aut |
700 | 1 | a Sánchez, Maria-Jose4 aut |
700 | 1 | a Amiano, Pilar4 aut |
700 | 1 | a Chirlaque, María-Dolores4 aut |
700 | 1 | a Gurrea, Aurelio Barricarte4 aut |
700 | 1 | a Johansson, Ingegerdu Umeå universitet,Onkologi4 aut0 (Swepub:umu)injo0003 |
700 | 1 | a Manjer, Jonas4 aut |
700 | 1 | a Perez-Cornago, Aurora4 aut |
700 | 1 | a Weiderpass, Elisabete4 aut |
700 | 1 | a Gunter, Marc J.4 aut |
700 | 1 | a Heath, Alicia K.4 aut |
700 | 1 | a Schalkwijk, Casper G.4 aut |
700 | 1 | a Jenab, Mazda4 aut |
710 | 2 | a Umeå universitetb Onkologi4 org |
773 | 0 | t Nutrientsd : MDPIg 13:9q 13:9x 2072-6643 |
856 | 4 | u https://doi.org/10.3390/nu13093132y Fulltext |
856 | 4 | u https://umu.diva-portal.org/smash/get/diva2:1621699/FULLTEXT01.pdfx primaryx Raw objecty fulltext:print |
856 | 4 | u https://www.mdpi.com/2072-6643/13/9/3132/pdf |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-190623 |
856 | 4 8 | u https://doi.org/10.3390/nu13093132 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.